New long-term data from Eli Lilly and Company (NYSE: LLY) show patients with moderately to severely active ulcerative colitis (UC) treated with Omvoh (mirikizumab-mrkz) achieved durable disease ...
LUCENT-3 trial open-label extension data show 63.5% of adults with ulcerative colitis administered mirikizumab (Omvoh) who ...
A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.
Even with biologics changing the treatment paradigm for ulcerative colitis more than 2 decades ago, patients have a similar ...
Treatment failure occurs when an ulcerative colitis medication isn’t helping symptoms. Most important, know that it’s not your fault. Learn what to do next.
GRAND RAPIDS, Mich. — If the Crohn’s & Colitis Foundation has anything to say about it, a cure for Crohn’s, Ulcerative Colitis, and many other conditions could be right around the corner. And for ...
Today, AbbVie (NYSE: ABBV) has announced two positive updates for Canadians living with UC, including those in Ontario and ...
Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...
Black, Hispanic and female patients with ulcerative colitis were significantly less likely to undergo colectomy compared with ...
Take Steps is a walk event that brings communities together to support people with inflammatory bowel disease (IBD) and their families. The event is happening on Saturday, June 8th, at 10 a.m. at ...